rna
interfer
rnai
provid
power
new
mean
inhibit
viral
infect
specif
howev
select
sirnaresist
virus
major
concern
use
rnai
antivir
therapeut
studi
conduct
lentivir
vector
hairpin
rna
shrna
express
cassett
deliv
small
interf
rna
sirna
mammalian
cell
use
vector
also
express
enhanc
green
fluoresc
protein
egfp
surrog
marker
stabl
shrnaexpress
cell
line
success
establish
inhibit
effici
ration
design
sirna
target
conserv
region
influenza
viru
genom
assess
result
show
sirna
target
influenza
gene
potent
inhibit
viral
replic
effect
viru
also
highli
pathogen
avian
influenza
viru
addit
inhibit
also
inhibit
np
mrna
accumul
protein
express
long
term
inhibit
effect
demonstr
emerg
sirnaresist
mutant
influenza
quasispeci
observ
taken
togeth
studi
suggest
gene
might
optim
rnai
target
antivir
therapi
find
provid
use
inform
develop
rnaibas
prophylaxi
therapi
human
influenza
viru
infect
influenza
viru
iav
remain
scourg
human
health
antigen
drift
shift
everchang
challeng
avail
vaccin
appear
drug
resist
main
hurdl
develop
antivir
drug
given
limit
current
antiinfluenza
viru
strategi
need
novel
strategi
prevent
treatment
iav
evid
regard
rna
interf
rnai
technolog
hold
great
promis
inhibit
replic
iav
includ
viru
rnai
form
posttranscript
gene
silenc
mediat
short
doublestrand
rna
known
small
interf
rna
sirna
process
cellular
complex
dicer
cleav
doublestrand
rna
dsrna
molecul
yield
doublestrand
duplex
nucleotid
length
sirna
guid
rnai
induc
silenc
complex
risc
cleav
target
mrna
share
sequenc
ident
sirna
sinc
first
demonstr
ad
exogen
synthet
sirna
molecul
mammalian
cell
induc
rnai
rapidli
expand
effort
develop
rnai
therapi
induc
degrad
target
messeng
rna
mrna
involv
genet
inherit
diseas
acquir
disord
iav
envelop
negativestrand
rna
viru
uniqu
properti
singlestrand
rna
viru
make
rnai
attract
approach
develop
antiavian
influenza
therapeut
singlestrand
viral
genom
consist
segment
contain
least
open
read
frame
orf
serv
templat
viral
genom
replic
subgenom
mrna
synthesi
report
sirna
respect
target
viral
gene
polymeras
polymeras
polymeras
pa
nucleocapsid
protein
np
nonstructur
protein
matrix
protein
especi
specif
np
pa
potent
inhibit
replic
influenza
virus
howev
report
hiv
hcv
may
develop
sirnaresist
mutat
quickli
therefor
abrog
rnai
treatment
thu
evalu
long
term
inhibit
effici
design
sirna
screen
emerg
sirna
resist
mutant
also
import
research
target
present
studi
identifi
effect
sirna
target
gene
highli
conserv
gene
iav
compar
report
effect
sirna
target
np
gene
sinp
establish
cell
line
stabli
express
shrna
transduc
lentiviralshrna
vector
madindarbi
canni
kidney
mdck
cell
use
two
cell
line
evalu
long
term
antivir
effect
sirna
iav
subtyp
screen
potenti
sirnaresist
viral
mutat
result
show
ration
design
confer
long
term
effect
inhibit
iav
replic
demonstr
sirnaresist
viral
mutat
appear
target
sequenc
even
viru
cultur
shrna
express
stabl
cell
line
passag
two
sirna
target
gene
ration
design
sirna
target
design
sequenc
sirna
shown
support
inform
tabl
effect
inhibit
viru
replic
assess
mdck
cell
two
sirna
target
np
gene
includ
experi
control
result
show
sirna
exhibit
good
inhibit
effect
dose
depend
manner
anoth
sirna
slightli
inhibit
viru
replic
even
concentr
nm
fig
fig
show
sirna
could
inhibit
influenza
viru
replic
sirna
inhibit
effect
consist
previou
report
exhibit
higher
inhibitori
effect
viru
sinp
stabl
cell
line
base
result
lentivirus
express
shrna
construct
transduc
mdck
cell
establish
two
stabl
cell
line
shnpmdck
mdck
cell
mdck
cell
transduc
blank
lentiviru
mock
mdck
use
control
cell
line
infect
viru
moi
cultur
supernat
harvest
indic
timepoint
determin
viru
titer
plaqu
assay
shown
fig
viru
replic
kinet
mock
mdck
similar
mdck
indic
lentiviru
integr
nt
influenc
viru
replic
viru
titer
shnpand
cell
cultur
fold
lower
control
mdck
mock
mdck
cultur
suggest
viru
replic
suppress
express
shrna
shnpmdck
cell
notabl
exhibit
better
inhibit
effect
show
lower
viral
titer
sinp
although
express
level
sinp
similar
dct
sinp
abolish
mrna
also
sinp
mrna
accumul
stabl
cell
line
also
measur
accumul
mrna
np
gene
infect
mdck
mock
mdck
shnpmdck
cell
mrna
extract
cell
harvest
hr
postinfect
test
realtim
rtpcr
mrna
express
level
normal
copi
confirm
whether
suppress
np
mrna
cell
inde
affect
np
protein
express
np
protein
level
test
indirect
immunofluoresc
assay
shown
fig
egfp
fluoresc
indic
shrna
express
detect
mock
mdck
shnpmdck
mdck
cell
np
protein
detect
mdck
mock
mdck
cell
shnpmdck
cell
result
consist
viral
mrna
result
indic
inde
suppress
np
protein
express
provid
potent
viral
effect
sinp
stabl
cell
line
test
whether
could
also
inhibit
replic
highli
pathogen
avian
influenza
viru
shown
fig
although
number
plaqu
similar
differ
mdck
cell
line
smaller
size
plaqu
found
cell
suggest
inhibit
replic
viru
cell
line
also
infect
differ
amount
viru
cultur
supernat
collect
differ
time
point
determin
viru
titer
ha
assay
viru
replic
significantli
inhibit
cell
timepoint
shnpmdck
offer
minor
inhibit
effect
earli
stage
viru
infect
fig
result
confirm
could
provid
potent
protect
sinp
infect
test
sirnaresist
viru
mutant
would
quickli
appear
cultur
cell
viru
continu
cultur
cell
passag
everi
passag
cultur
supernat
collect
test
plaqu
reduct
assay
obviou
larger
size
plaqu
found
ten
plaqu
rel
larger
size
pick
identifi
potenti
mutat
sirna
target
region
sequenc
result
show
mutat
appear
target
region
even
passag
cultur
fig
princip
find
studi
ration
design
sirna
target
influenza
gene
confer
effect
long
term
inhibit
influenza
viru
replic
high
suppress
effect
influenza
viru
also
highli
pathogen
subtyp
previou
relat
studi
ge
cowork
screen
sirna
target
conserv
gene
influenza
viru
show
best
sinc
confer
inhibit
viru
li
et
al
tomkin
et
al
confirm
provid
high
effect
therefor
includ
posit
control
studi
result
show
sirna
exhibit
similar
fig
even
slight
higher
fig
inhibitori
effect
iav
replic
compar
recent
report
zhou
et
al
also
show
sever
sirna
target
np
gene
exhibit
effect
inhibit
influenza
viru
replic
cultur
mdck
cell
anim
model
howev
sequenc
report
sirna
target
gene
complet
differ
sirna
furthermor
chemic
synthes
sirna
plasmid
base
shrna
alway
deliv
transfect
previou
relat
studi
wherea
use
lentiviru
system
deliv
select
shrna
although
integr
properti
lentiviru
abrog
use
human
help
studi
purpos
success
establish
stabl
cell
line
persist
express
sirna
studi
found
decreas
level
mrna
also
level
np
mrna
suggest
broad
inhibit
manner
process
influenza
viru
replic
ge
et
al
report
similar
broad
inhibit
sirna
studi
provid
broad
inhibit
influenza
viru
abolish
accumul
specif
np
pa
mrna
also
inhibit
accumul
mrna
pa
np
gene
possibl
explan
doubl
strand
sirna
may
result
ifn
respons
activ
rna
degrad
pathway
eg
phosphoryl
protein
kinas
r
pkr
howev
mechan
broad
inhibit
sirna
still
clear
yet
standpoint
viral
target
choic
rnai
base
antivir
therapi
np
protein
requir
elong
antitermin
nascent
crna
vrna
transcript
without
newli
synthes
np
viral
transcript
replic
block
play
critic
role
assembl
infecti
viru
particl
thu
potent
antivir
effect
may
attribut
broad
inhibitori
effect
depend
stringenc
sirnatarget
base
pair
sirna
treatment
may
caus
select
sirnaresist
virus
shown
hiv
hcv
therefor
abrog
medic
treatment
use
lentivir
deliveri
system
establish
stabl
cell
line
persist
express
shrna
provid
conveni
experiment
approach
studi
long
term
inhibit
effect
sirna
screen
sirna
resist
viru
mutant
quasispeci
vitro
result
show
viru
cultur
equal
suscept
origin
viru
even
passag
moreov
sequenc
target
region
independ
plaqu
purifi
viru
isol
reveal
sequenc
ident
parent
one
current
data
shown
insert
delet
nucleotid
substitut
sirna
target
sequenc
therefor
demonstr
possess
good
long
term
inhibit
effect
influenza
viru
replic
without
problem
sirna
resist
mutant
taken
togeth
find
effect
rnai
target
lentivir
vector
deliveri
establish
stabl
shrna
express
cell
line
studi
provid
ration
inform
develop
sirna
prophylaxi
therapi
influenza
viru
infect
human
mdck
human
embryon
kidney
cell
respect
maintain
mem
dmem
invitrogen
usa
supplement
heatinactiv
fetal
bovin
serum
fb
antibiot
u
penicillin
gml
ug
streptomycinml
influenza
viru
strain
anew
caledonia
ahong
use
experi
prepar
mdck
cell
viru
titer
determin
tcid
experi
viru
perform
laboratori
sirna
target
np
gene
influenza
viru
design
sirna
target
design
version
promega
http
wwwpromegacomsirnadesignerprogram
duplex
design
previous
report
sirna
synthes
invitrogen
usa
sequenc
shown
support
inform
tabl
sirna
revers
transfect
mdck
cell
use
lipofectamin
tm
rnaimax
invitrogen
usa
describ
compani
instruct
incub
cell
hr
cell
infect
virus
follow
detect
viral
replic
hour
infect
rna
extract
cell
follow
real
time
rtpcr
detect
rel
quantiti
replic
viral
rna
shrna
cassett
construct
anneal
two
primer
contain
sens
revers
complementari
target
sequenc
loop
ttcaagagaand
flank
clone
site
sequenc
shrna
shown
support
inform
tabl
clone
promot
lvthm
plasmid
sequenc
insert
confirm
dna
sequenc
lentivir
vector
shrna
express
cassett
produc
calcium
phosphatemedi
threeplasmid
transfect
cell
briefli
cell
mdck
stabl
shrna
express
cell
line
plate
infect
virus
moi
mgml
trypsin
use
infect
process
incub
hr
infect
medium
remov
mem
without
fb
ad
cell
supernat
collect
differ
time
point
viral
load
detect
hemagglutin
ha
andor
plaqu
assay
describ
previous
briefli
ha
assay
carri
ubottom
well
plate
serial
dilut
viru
sampl
mix
equal
volum
suspens
turkey
erythrocyt
lampir
biolog
laboratori
pipersvil
usa
incub
room
temperatur
rt
min
well
contain
adher
homogen
layer
erythrocyt
score
posit
plaqu
assay
serial
dilut
viru
sampl
ad
monolay
mdck
cell
hr
incub
viru
remov
cultur
overlaid
semi
solid
agarmem
three
day
infect
plaqu
visual
stain
crystal
violent
realtim
rtpcr
carri
describ
previous
briefli
viru
infect
mdck
mock
mdck
shnpmdck
harvest
hr
infect
total
rna
extract
infect
cell
sampl
use
rneasi
rna
isol
kit
qiagen
germani
revers
transcrib
use
superscript
ii
revers
transcriptas
oligo
dt
primer
invitrogen
usa
accord
manufactur
protocol
viral
mrna
copi
measur
sybr
green
realtim
pcr
system
indirect
immunofluoresc
assay
perform
describ
previous
modif
mdck
mock
mdck
shnpmdck
cell
grew
micro
cover
glass
thoma
usa
infect
moi
viru
hr
wash
pb
cell
fix
paraformaldehyd
min
rt
permeabil
triton
min
rt
wash
pb
cell
incub
dilut
mous
antinp
antibodi
abcam
uk
min
dark
rt
cell
wash
three
time
pb
fc
incub
dilut
texa
redconjug
antimous
lgg
abcam
uk
min
dark
rt
cell
wash
mount
slide
view
olympu
fluoresc
microscop
olympu
germani
screen
potenti
sirna
resist
mutant
perform
establish
stabl
shrnaexpress
cell
line
accord
previous
describ
protocol
modif
briefli
cell
cm
flask
infect
viru
cultur
day
supernat
harvest
part
supernat
inocul
next
passag
viru
cultur
anoth
part
subject
plaqu
assay
determin
potenti
sirnaresist
viru
appear
everi
passag
ten
bigger
size
plaqu
plaqu
assay
pick
sequenc
detect
mutat
sirna
target
region
use
pair
primer
forward
gca
gat
ggt
gca
ggc
revers
tcc
agc
tct
atg
ctg
tabl
found
mb
doc
